Trade Mark Journal No.2025/022 30 May 2025

WO0000001842323 (5,42)

Office of origin: United States of America

Date of International Registration:19 December 2024
Date of designation in the UK: 19 December 2024
Image for mark 1842323 FARADAY PHARMACEUTICALS

Registration of this mark shall give no right to the exclusive use of the word "PHARMACEUTICALS".

Class 5
Pharmaceutical preparations for the prevention and treatment of cardiac and skeletal muscle function disorders.
Class 42
Providing information in the field of testing of pharmaceuticals via a website; research and development in the field of pharmaceuticals.

Faraday Pharmaceuticals, Inc.

Representative: Susan Piascik Christoff Cooley LLP, 1299 Pennsylvania Avenue, NW, Suite 700, Washington DC 20004, UNITED STATES OF AMERICA